Ensysce Biosciences Inc. (ENSC)
7.09
0.34 (5.04%)
At close: Jan 15, 2025, 12:35 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -3.39 | -0.97 | -48.78 | -3.13K | 2.50K | -2.74K | -116.94K |
| PS Ratio | 16.14 | 9.63 | 402.58 | 748.16 | 2.09K | n/a | n/a |
| PB Ratio | -111.5 | -6.03 | -174.26 | -456.65 | 19.80 | 18.63 | 18.68 |
| P/FCF Ratio | -3.34 | -1.36 | -172.48 | -2.36K | 335.25 | -2.97K | -14.48K |
| P/OCF Ratio | -3.34 | -1.36 | -172.48 | -2.36K | 335.25 | -2.97K | -14.48K |
| OCF/S Ratio | -4.83 | -7.09 | -2.33 | -0.32 | 6.23 | n/a | n/a |
| Debt / Equity Ratio | -2.65 | -1.09 | -1.56 | -0.66 | 0.00 | n/a | n/a |
| Quick Ratio | 0.69 | 0.59 | 0.98 | 0.05 | 0.43 | 4.38 | 14.77 |
| Current Ratio | 0.69 | 0.56 | 0.95 | 0.05 | 0.43 | 4.38 | 14.77 |
| Asset Turnover | 0.82 | 0.43 | 0.22 | 11.17 | 0.01 | n/a | n/a |
| Interest Coverage | -30.28 | -221.16 | -15.34 | -1.62 | n/a | n/a | n/a |
| Return on Equity (ROE) | 32.87 | 6.19 | 3.57 | 0.15 | 0.01 | -0.01 | -0.00 |
| Return on Assets (ROA) | -3.92 | -4.24 | -1.78 | -2.67 | 0.01 | -0.01 | -0.00 |
| Return on Capital (ROIC) | 17.15 | 6.77 | 308.95 | 0.24 | -0.02 | -0.00 | -0.00 |
| Dividend Yield | n/a | 0.04 | 564.96 | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | -0.04 | -27.56K | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -240.17% | -686.08% | 100.00% | 65.18% | -88.7% | n/a | n/a |
| Net Profit Margin | -475.81% | -989.21% | -825.38% | -23.88% | 83.70% | n/a | n/a |
| Pretax Profit Margin | -476.4% | -959.33% | -825.38% | -4.09% | 52.22% | n/a | n/a |
| Operating Profit Margin | -480.52% | -959.91% | -562.71% | -41.04% | -188.7% | n/a | n/a |
| FCF Margin | -483.29% | -708.87% | -233.41% | -31.73% | 623.31% | n/a | n/a |
| EBITDA Margin | -480.52% | -959.91% | -562.71% | -41.03% | 52.22% | n/a | n/a |